BMO raises HubSpot stock price target to $255 on steady SMB trends

BMO raised its Atlassian price target to $225 from $170 and retained Outperform, while raising HubSpot’s target to $255 from $250 and maintaining Market Perform. Analysts cited Atlassian’s Cloud, subscription and AI-driven growth prospects; BMO also noted that SMB buying cycles could remain elongated as buyers consider more AI solutions. Options data ahead of Atlassian’s November 5 earnings points to a potential 13% stock move, according to the article.

Analysis

The actionable signal is less the target revisions than the divergence in demand risk: TEAM’s upside case depends on converting Cloud/AI interest and usage-based pricing into measurable paid consumption, while HUBS faces a more direct risk that AI evaluation lengthens SMB buying cycles. For HUBS, longer evaluation can defer bookings and raise sales-efficiency costs even if eventual demand holds; it also gives buyers more leverage to compare CRM and marketing tools, potentially benefiting Salesforce and other alternatives. Treat this as a timing risk, not evidence of structural churn.

TEAM’s sharp prior run-up and clustered bullish analyst calls raise the bar for earnings: positive commentary on AI or Cloud may already be priced in unless usage, subscription growth, or guidance demonstrates monetization. The reported options-implied move makes the November 5 event a volatility catalyst, but the historical tendency to exceed implied moves is not a directional edge. The third-party fair-value estimate is not independent evidence of undervaluation.

Near term, expect elevated event sensitivity and potential post-earnings repricing. Over 1–3 months, watch Cloud/subscription metrics, usage-pricing adoption, and forward guidance. Over 6–18 months, AI could expand software budgets, but also intensify product substitution and lengthen procurement as customers rationalize overlapping tools. The bullish thesis is falsified by weaker-than-guided Cloud/subscription trends or lack of evidence that usage pricing lifts paid consumption; HUBS downside risk eases if SMB sales cycles normalize without deterioration in bookings.

Key Decisions for Investors

• TEAM: Avoid chasing into earnings after the rally and bullish target clustering. Reassess after November 5; add only if Cloud/subscription performance and forward guidance validate paid usage growth. A guidance or usage shortfall would challenge the rerating.
• TEAM event risk: Options imply a large move, but direction is unclear. Do not sell volatility solely on the assumption the market has overestimated the event; verify current implied volatility, skew, and the cost of defined-risk structures before considering any options position.
• HUBS: Keep at watch status rather than treating BMO’s modest target increase as a catalyst. Track SMB sales-cycle commentary, bookings, and guidance; persistent elongation or weaker bookings would support relative underperformance versus software peers, while normalization would weaken that view.
• Monitor competitive evidence over the next 1–3 months: whether AI features generate paid adoption or merely extend evaluation and procurement. Lack of monetization across both names would argue against paying a broad AI-software premium.